Vaylen review
Every figure on the page is a twelve-month program paid upfront.
The verdict
Vaylen publishes three prices and all three are twelve-month programs billed in one payment. Its own footnote says so. The same footnote states that shorter and monthly plans exist, and prints no figure for any of them.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- States
- 50
- Injection
- From $83.25/mo
- Oral
- From $99/mo
- Dose published
- No
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
Vaylen sells compounded semaglutide and compounded tirzepatide as weekly injections, plus a daily dissolvable semaglutide tablet. Weight loss is the only line open. Men's health, women's health, hair loss and longevity are listed as pre-launch waitlists.
Who writes the prescription, and what do they see?
Clinical services are provided through a named external clinician network rather than by Vaylen itself. The site states a board-certified US clinician reads each intake within twenty-four hours and that no approval is automated. A declined patient is refunded in full. No individual clinician is named.
A program covers the prescription, the medication, provider check-ins and shipping. Monthly check-ins, dose adjustments and safety labs are listed as part of it. The site states there is no membership fee underneath. Payment can be split through two financing providers.
What happens when the dose goes up?
Dose is stated to be matched to the goal and adjusted monthly as the body responds. Safety labs are named as part of that. No milligram figure appears beside any plan. Nothing published says what a step up costs inside a twelve-month term.
What the price includes
Semaglutide, tirzepatide and the oral tablet each carry a monthly-looking figure. The footnote attached to all three states the figure is the per-month cost of a twelve-month program billed upfront. A separate first-month price appears in the weight-loss panel. No month-to-month rate is published anywhere.
What it claims, and what it cites
Both molecules are offered compounded. The footer states that compounded medications are not FDA-approved finished products and have not been evaluated by the FDA. It also states FDA-approved medication may be prescribed where clinically appropriate. Pharmacies are described as licensed United States facilities and not named.
Where it holds up, and where it does not
- Strength: The commitment term is printed in the footnote, not hidden
- Strength: A declined patient is refunded in full
- Strength: Monthly check-ins and safety labs are named
- Strength: The clinician network is named in the footer
- Strength: Financing is offered on the upfront payment
- Limitation: Every published rate requires a twelve-month prepayment
- Limitation: No month-to-month figure appears anywhere
- Limitation: No milligram dose is published
- Limitation: Four of the five advertised lines are waitlists
What the evidence says about this kind of treatment
The assessment above is about Vaylen. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A buyer ready to pay twelve months at once for the lowest stated rate.
- Wrong for
- A buyer who wants to compare a monthly bill against another monthly bill.
The evidence behind what Vaylen prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Vaylen compares
| Seller | Who it suits | Go |
|---|---|---|
 Ondra Health | Buyers who want the billed total printed beside the monthly figure before they choose a term | See Ondra Health → |
 DreamHug Medical | A reader signing for the longest term who needs a broad list of served states | See DreamHug Medical → |
| Big Easy Weight Loss | Readers who can pay a block up front and want the new-patient reduction | See Big Easy Weight Loss → |
More GLP-1 telehealth sellers reviews: Midi HealthMint MedMint Medical ClinicMochi HealthMojoonMondae
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Can I pay monthly?
- The footnote says shorter programs and monthly plans are available. No figure is published for either.
- What happens if the clinician declines me?
- The site states a full refund. Prescriptions are issued only after an individual clinical evaluation.
- Who provides the care?
- A named external network of licensed US clinicians. Vaylen states it is not itself a medical provider.
- Is Vaylen expensive compared with other GLP-1 telehealth sellers?
- Vaylen publishes a starting figure of $83.25/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Vaylen below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.